ACTIVE

Apotheek Lisp

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

170,2 k €

+27.5% YoY

Gross margin

401,3 k €

+8.7% YoY

Equity

328,7 k €

+5.7% YoY

Workforce

2,3 ETP

0.0% YoY

What does Apotheek Lisp do?

Apotheek Lisp is a Private limited company incorporated in 1997. Its registered office is in Lier. It employs on average 2,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0459.491.176

Incorporation

02/01/1997

Legal form

Private limited company

Registered office

Lispersteenweg 182/B
2500 Lier · FlandreSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2025

Average workforce

2,3 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	401,3 k €	+8.7%	369,2 k €	+16.7%	316,4 k €	+5.3%	300,4 k €	+4.8%	286,6 k €	+14.7%	249,9 k €	+15.1%	217,1 k €	+8.7%	199,7 k €	+14.9%	173,7 k €	-4.3%	181,6 k €	-7.9%	197,2 k €	+1.7%	193,9 k €	-5.5%	205,1 k €	+4.7%	196 k €	+26.1%	155,3 k €	+5.7%	147 k €	+1.6%	144,7 k €	+11.6%	129,6 k €	-24.8%	172,4 k €	+19.0%	145 k €
EBITDA	236,8 k €	+10.3%	214,7 k €	+29.1%	166,3 k €	-14.1%	193,7 k €	-0.9%	195,5 k €	+12.6%	173,7 k €	+16.0%	149,7 k €	+9.0%	137,4 k €	+35.8%	101,1 k €	+15.3%	87,7 k €	-19.8%	109,4 k €	+6.4%	102,8 k €	-11.2%	115,9 k €	+4.0%	111,4 k €	+46.4%	76,1 k €	+19.5%	63,7 k €	+16.2%	54,8 k €	+2.2%	53,7 k €	-43.0%	94,1 k €	+22.2%	77,1 k €
Operating result	185,1 k €	+23.6%	149,7 k €	+44.7%	103,5 k €	-20.9%	130,8 k €	-2.2%	133,7 k €	+28.9%	103,7 k €	+1.4%	102,3 k €	+10.4%	92,7 k €	+60.6%	57,7 k €	+47.6%	39,1 k €	-41.1%	66,3 k €	+14.1%	58,2 k €	-19.2%	72 k €	+5.0%	68,6 k €	+62.1%	42,3 k €	-18.5%	51,9 k €	+46.6%	35,4 k €	+8.0%	32,8 k €	-55.8%	74,1 k €	+77.6%	41,7 k €
Net result	170,2 k €	+27.5%	133,5 k €	+48.8%	89,7 k €	-23.3%	117 k €	+0.3%	116,7 k €	+30.9%	89,1 k €	-6.1%	94,9 k €	+14.1%	83,1 k €	+78.4%	46,6 k €	+157%	18,2 k €	-42.8%	31,7 k €	+17.7%	27 k €	-17.8%	32,8 k €	+30.5%	25,1 k €	+130%	10,9 k €	-56.5%	25,1 k €	+80.4%	13,9 k €	+42.8%	9,7 k €	-78.3%	44,9 k €	+216%	14,2 k €
Balance sheet
Equity	328,7 k €	+5.7%	311 k €	+7.4%	289,5 k €	+5.4%	274,7 k €	+8.7%	252,7 k €	+8.0%	234 k €	+0.9%	231,9 k €	+3.5%	224 k €	+0.1%	223,9 k €	+0.6%	222,6 k €	+3.1%	215,9 k €	+17.2%	184,2 k €	+17.2%	157,2 k €	+26.4%	124,4 k €	-3.8%	129,3 k €	+9.2%	118,4 k €	+26.9%	93,3 k €	+17.5%	79,4 k €	+14.0%	69,6 k €	+55.8%	44,7 k €
Total assets	846,9 k €	+3.3%	819,4 k €	+4.6%	783,8 k €	-4.7%	822,7 k €	-14.1%	957,9 k €	+1.1%	947,1 k €	+29.3%	732,6 k €	-0.3%	734,7 k €	+1.1%	727 k €	+0.6%	722,6 k €	+74.7%	413,7 k €	+3.6%	399,3 k €	-3.2%	412,7 k €	-0.1%	413,3 k €	+3.4%	399,6 k €	+64.7%	242,6 k €	+21.9%	199,1 k €	-5.7%	211,1 k €	-14.1%	245,8 k €	+5.7%	232,5 k €
Cash	222,6 k €	+34.8%	165,2 k €	+53.7%	107,5 k €	-7.5%	116,2 k €	-46.3%	216,3 k €	+24.7%	173,5 k €	+22.1%	142,1 k €	-10.1%	158 k €	+32.3%	119,4 k €	-32.8%	177,7 k €	+41.3%	125,8 k €	+71.3%	73,5 k €	+51.9%	48,4 k €	+9.9%	44 k €	+348%	9,8 k €	-65.9%	28,8 k €	+1367%	2 k €	-87.5%	15,7 k €	-55.9%	35,5 k €	+141%	14,7 k €
Debts	511,3 k €	+2.2%	500,5 k €	+2.5%	488,2 k €	-9.9%	542,2 k €	-22.4%	699,1 k €	-1.3%	708,3 k €	+42.8%	496 k €	-1.9%	505,8 k €	+1.9%	496,2 k €	-0.0%	496,3 k €	+152%	197 k €	-8.4%	215,1 k €	-15.8%	255,5 k €	-11.6%	288,8 k €	+6.8%	270,3 k €	+127%	118,9 k €	+13.0%	105,2 k €	-18.6%	129,2 k €	-26.6%	176,1 k €	-6.2%	187,8 k €
Other
Workforce	2,3 ETP	0.0%	2,3 ETP	-4.2%	2,4 ETP	+20.0%	2,0 ETP	+25.0%	1,6 ETP	+14.3%	1,4 ETP	+27.3%	1,1 ETP	+10.0%	1,0 ETP	-23.1%	1,3 ETP	-13.3%	1,5 ETP	0.0%	1,5 ETP	-6.3%	1,6 ETP	+6.7%	1,5 ETP	0.0%	1,5 ETP	0.0%	1,5 ETP	+15.4%	1,3 ETP	-27.8%	1,8 ETP	-5.3%	1,9 ETP	+18.7%	1,6 ETP	+6.7%	1,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

STEANN PHARMA

Director · 0660.893.761

Represented by Anneleen De Swert

Active

Ended mandates

STEANN PHARMA

Manager · since 01 septembre 2016 · 0660.893.761

Represented by Anneleen De Swert

Ended

Pia Cuypers

Mandate

Ended

Pia Cuypers

Administrator - manager

Ended

Pia Cuypers

Manager · until 31 août 2016

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/07/2026	17/07/2025	22/07/2024	27/07/2023	29/07/2022	12/07/2021
General meeting	30/06/2026	17/06/2025	30/06/2024	30/06/2023	30/06/2022	15/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	28/07/2026	Dutch	PDF
Abridged model	31/12/2024	17/06/2025	17/07/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	22/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	27/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	29/07/2022	Dutch	PDF
Abridged model	31/12/2020	15/06/2021	12/07/2021	Dutch	PDF
Abridged model	31/12/2019	16/06/2020	10/07/2020	Dutch	PDF
Abridged model	31/12/2018	18/06/2019	05/07/2019	Dutch	PDF
Abridged model	31/12/2017	19/06/2018	25/06/2018	Dutch	PDF
Abridged model	31/12/2016	20/06/2017	26/06/2017	Dutch	PDF
Abridged model	31/12/2015	07/06/2016	01/07/2016	Dutch	PDF
Abridged model	31/12/2014	16/06/2015	15/07/2015	Dutch	PDF
Abridged model	31/12/2013	17/06/2014	07/07/2014	Dutch	PDF
Abridged model	31/12/2012	18/06/2013	21/06/2013	Dutch	PDF
Abridged model	31/12/2011	19/06/2012	10/07/2012	Dutch	PDF
Abridged model	31/12/2010	21/06/2011	20/07/2011	Dutch	PDF
Abridged model	31/12/2009	15/06/2010	14/07/2010	Dutch	PDF
Abridged model	31/12/2008	16/06/2009	10/07/2009	Dutch	PDF
Abridged model	31/12/2007	17/06/2008	14/07/2008	Dutch	PDF
Abridged model	31/12/2006	19/06/2007	13/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

STEANN PHARMA

Director · 0660.893.761

Represented by Anneleen De Swert

Active

Ended mandates

STEANN PHARMA

Manager · since 01 septembre 2016 · 0660.893.761

Represented by Anneleen De Swert

Ended

Pia Cuypers

Mandate

Ended

Pia Cuypers

Administrator - manager

Ended

Pia Cuypers

Manager · until 31 août 2016

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates19/01/2024
WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/09/2016
BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares30/04/2004
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025170,2 k €↑
2024
Annual accounts 2024133,5 k €↑
2023
Annual accounts 202389,7 k €↓
2022
Annual accounts 2022117 k €↑
2021
Annual accounts 2021116,7 k €↑
2020
Annual accounts 202089,1 k €↓
2019
Annual accounts 201994,9 k €↑
2018
Annual accounts 201883,1 k €↑
2017
Annual accounts 201746,6 k €↑
2016
Annual accounts 201618,2 k €↓
2016
Name changeApotheek Lisp
2015
Annual accounts 201531,7 k €↑
2014
Annual accounts 201427 k €↓
2013
Annual accounts 201332,8 k €↑
2012
Annual accounts 201225,1 k €↑
2011
Annual accounts 201110,9 k €↓
2010
Annual accounts 201025,1 k €↑
2009
Annual accounts 200913,9 k €↑
2008
Annual accounts 20089,7 k €↓
2007
Annual accounts 200744,9 k €↑
2006
Annual accounts 200614,2 k €
2006
Name changeApotheek PIA CUYPERS
02/01/1997
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Apotheek Lisp

Overview

What does Apotheek Lisp do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline